<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04541121</url>
  </required_header>
  <id_info>
    <org_study_id>2001287</org_study_id>
    <nct_id>NCT04541121</nct_id>
  </id_info>
  <brief_title>3D Maternal Fetal Attachment and Smoking</brief_title>
  <official_title>Effects of 3D Ultrasonography and 3D Printed Images on Maternal-fetal Attachment and Its Correlation With Overall Smoking Within Pregnancy and Smoking Cessation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Creighton University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Creighton University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether 3D models of fetus' face created from 3D ultrasound will increase&#xD;
      maternal attachment and aid in smoking cessation. Half of participants will receive 3D model&#xD;
      and half will receive a picture of 3D ultrasound of their baby&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 30, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>3D ultrasound and picture of ultrasound or 3D ultrasound and printed model of fetal face</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal Antenatal Attachment Scale (MAAS)</measure>
    <time_frame>5 minutes</time_frame>
    <description>The MAAS is a 19 item questionnaire measuring maternal-fetal attachment. Each item has five answer choices scored from 1 low attachment to 5 high attachment such that the total score ranges from 19 to 95. The measure also includes two subscales: (1) Quality of Attachment has 10 items with a range of 10-50 and measures the quality of the mother's attachment to her fetus. (2) Time measures the time spent in attachment mode (or intensity of preoccupation) and consists of 8 items for a range of 8 to 40. (for clarity one item included in the total score is not included in either subscale.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Timeline Follow Back (TLFB):</measure>
    <time_frame>10 minutes</time_frame>
    <description>This semi-structured interview utilizes a calendar to aid in participants' recall of smoking throughout pregnancy. The TLFB method is the preferred approach to measure substance use and has shown reliability when used for pregnant women in previous studies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Salivary cotinine</measure>
    <time_frame>5 minutes</time_frame>
    <description>Cotinine is a stable nicotine metabolite produced by the liver. This is to test amount mother has smoked.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Maternal-Fetal Relations</condition>
  <condition>Maternal Behavior</condition>
  <arm_group>
    <arm_group_label>3D printed model</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mother is given 3D printed model of fetus' face</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Mother is given printed picture of 3D ultrasound of fetus</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>3D printed model</intervention_name>
    <description>Mother is given 3D printed model of fetus' face</description>
    <arm_group_label>3D printed model</arm_group_label>
    <other_name>Mother is given 3D printed model of fetus' face</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Mother is given a picture of 3D ultrasound of fetus</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age - Female 19-45 years of age&#xD;
&#xD;
          -  Fluent in English&#xD;
&#xD;
          -  Currently smoking cigarettes&#xD;
&#xD;
          -  Currently pregnant (between 21- and 36-weeks' gestation)&#xD;
&#xD;
          -  Have normal 20-week ultrasound&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having received more than 3 ultrasounds prior to study&#xD;
&#xD;
          -  Medical need for additional ultrasounds&#xD;
&#xD;
          -  Multiple fetuses&#xD;
&#xD;
          -  &gt; 31 weeks gestation&#xD;
&#xD;
          -  Does not smoke cigarettes&#xD;
&#xD;
          -  Is not fluent in English&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>women currently pregnant (between 21- and 36-weeks' gestation)</gender_description>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Cote, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Creighton University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Cote, MD</last_name>
    <phone>4023438511</phone>
    <email>john.cote@alegent.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline A Nubel, BPS</last_name>
    <phone>4022804032</phone>
    <email>carolinenubel@creighton.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Creighton University</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68178</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Nicole Santek</last_name>
      <phone>402-280-2322</phone>
      <email>nicolesantek@creighton.edu</email>
    </contact>
    <investigator>
      <last_name>Amy Badura Brack, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 1, 2020</study_first_submitted>
  <study_first_submitted_qc>September 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2020</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

